Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of apelin on insulin sensitivity in type 2 diabetic volunteers
2015-004875-61Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of apelin-13 in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Insulin sensitivity measured by glucose infusion rate. Started Dec 2015; status: completed.
02
Drugs
apelin-13
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-004875-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004875-61.